|
Q3 2017
Filed on Nov 14, 2017
|
48,000,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
4,752,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
281,831
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
77,661
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
27,617
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
305,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
291,475
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
592,618
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
16,238,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
77,867
|
$30.96 - $34.4
$2.41M - $2.68M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
740,262
|
N/A
|
|
Nord Anglia Education Inc
|
Q3 2017
Filed on Nov 14, 2017
|
768,587
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
2,728,831
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
120,281
|
$33.46 - $34.82
$4.02M - $4.19M
|
|
Chicago Bridge & Iron CO N V
|
Q3 2017
Filed on Nov 14, 2017
|
23,983
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
8,796
|
$36.95 - $43.85
$325K - $386K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
42,567
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
30,180
|
$102.94 - $110.92
$3.11M - $3.35M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
50,403
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
34,093
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
8,917
|
$45.39 - $51.81
$405K - $462K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
292,541
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
66,580
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
713,054
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
493,750
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
2,239,558
|
$11.7 - $13.15
$26.2M - $29.5M
|
|
Valeant Pharmaceuticals Intl
|
Q3 2017
Filed on Nov 14, 2017
|
186,346
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
3,666
|
$80.62 - $86.05
$296K - $315K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
28,371
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
53,592
|
$31.66 - $37.16
$1.7M - $1.99M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
51,755
|
$210.25 - $271.0
$10.9M - $14M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
1,040,992
|
N/A
|
|